Quick Answer
Beta Bionics, Inc. reported Gross Profit of $55.54 million for fiscal year 2025.
Beta Bionics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $55.54M | +54.8% |
| 2024 | $35.89M | +468.9% |
| 2023 | $6.31M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.12M | +69.6% | +20.9% |
| June 30, 2025 | $12.50M | +54.7% | +39.4% |
| March 31, 2025 | $8.97M | +24.6% | +0.6% |
| September 30, 2024 | $8.91M | — | +10.3% |
| June 30, 2024 | $8.08M | — | +12.3% |
| March 31, 2024 | $7.20M | — | — |
- Beta Bionics, Inc. showed an increase of +54.8% in Gross Profit compared to the prior fiscal year.
- Over the 2023–2025 period, Beta Bionics, Inc.’s gross profit has grown by 780.4% (from $6.31 million to $55.54 million).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: